| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |